aluates Reports

$ 0.0

Automative

Global Acquired Hemophilia Treatment Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-17Z1141

Global Acquired Hemophilia Treatment Market Insights and Forecast to 2028

BUY CHAPTERS

Global Acquired Hemophilia Treatment Market Research Report 2024

Code: QYRE-Auto-17Z1141

Report

January 2024

Pages:70

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Baxalta

Baxter Healthcare Corporation

Bristol–Myers Squibb

Genentech Inc

Sanofi SA

Acquired Hemophilia Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Acquired Hemophilia Treatment Market

Acquired hemophilia is a rare autoimmune disorder characterized by bleeding that occurs in patients with a personal and family history negative for hemorrhages.

The global Acquired Hemophilia Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Acquired Hemophilia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acquired Hemophilia Treatment.

Report Scope

The Acquired Hemophilia Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acquired Hemophilia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Acquired Hemophilia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Acquired Hemophilia Treatment Market Report

Report Metric	Details
Report Name	Acquired Hemophilia Treatment Market
CAGR	5%
Segment by Type	Traditional Therapy Advanced Therapy
Segment by Application	Hospitals Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Baxalta, Inc., Baxter Healthcare Corporation, Bristol-Myers Squibb, Genentech, Inc., Novo Nordisk A/S, Ferring B.V., Sanofi SA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acquired Hemophilia Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Acquired Hemophilia Treatment Market report?

Ans: The main players in the Acquired Hemophilia Treatment Market are Baxalta, Inc., Baxter Healthcare Corporation, Bristol-Myers Squibb, Genentech, Inc., Novo Nordisk A/S, Ferring B.V., Sanofi SA

What are the Application segmentation covered in the Acquired Hemophilia Treatment Market report?

Ans: The Applications covered in the Acquired Hemophilia Treatment Market report are Hospitals, Clinic, Others

What are the Type segmentation covered in the Acquired Hemophilia Treatment Market report?

Ans: The Types covered in the Acquired Hemophilia Treatment Market report are Traditional Therapy, Advanced Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Acquired Hemophilia Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Traditional Therapy

1.2.3 Advanced Therapy

1.3 Market by Application

1.3.1 Global Acquired Hemophilia Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Acquired Hemophilia Treatment Market Perspective (2019-2030)

2.2 Acquired Hemophilia Treatment Growth Trends by Region

2.2.1 Global Acquired Hemophilia Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Acquired Hemophilia Treatment Historic Market Size by Region (2019-2024)

2.2.3 Acquired Hemophilia Treatment Forecasted Market Size by Region (2025-2030)

2.3 Acquired Hemophilia Treatment Market Dynamics

2.3.1 Acquired Hemophilia Treatment Industry Trends

2.3.2 Acquired Hemophilia Treatment Market Drivers

2.3.3 Acquired Hemophilia Treatment Market Challenges

2.3.4 Acquired Hemophilia Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Acquired Hemophilia Treatment Players by Revenue

3.1.1 Global Top Acquired Hemophilia Treatment Players by Revenue (2019-2024)

3.1.2 Global Acquired Hemophilia Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Acquired Hemophilia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Acquired Hemophilia Treatment Revenue

3.4 Global Acquired Hemophilia Treatment Market Concentration Ratio

3.4.1 Global Acquired Hemophilia Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Acquired Hemophilia Treatment Revenue in 2023

3.5 Acquired Hemophilia Treatment Key Players Head office and Area Served

3.6 Key Players Acquired Hemophilia Treatment Product Solution and Service

3.7 Date of Enter into Acquired Hemophilia Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Acquired Hemophilia Treatment Breakdown Data by Type

4.1 Global Acquired Hemophilia Treatment Historic Market Size by Type (2019-2024)

4.2 Global Acquired Hemophilia Treatment Forecasted Market Size by Type (2025-2030)

5 Acquired Hemophilia Treatment Breakdown Data by Application

5.1 Global Acquired Hemophilia Treatment Historic Market Size by Application (2019-2024)

5.2 Global Acquired Hemophilia Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Acquired Hemophilia Treatment Market Size (2019-2030)

6.2 North America Acquired Hemophilia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Acquired Hemophilia Treatment Market Size by Country (2019-2024)

6.4 North America Acquired Hemophilia Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Acquired Hemophilia Treatment Market Size (2019-2030)

7.2 Europe Acquired Hemophilia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Acquired Hemophilia Treatment Market Size by Country (2019-2024)

7.4 Europe Acquired Hemophilia Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Acquired Hemophilia Treatment Market Size (2019-2030)

8.2 Asia-Pacific Acquired Hemophilia Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Acquired Hemophilia Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Acquired Hemophilia Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Acquired Hemophilia Treatment Market Size (2019-2030)

9.2 Latin America Acquired Hemophilia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Acquired Hemophilia Treatment Market Size by Country (2019-2024)

9.4 Latin America Acquired Hemophilia Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Acquired Hemophilia Treatment Market Size (2019-2030)

10.2 Middle East & Africa Acquired Hemophilia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Acquired Hemophilia Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Acquired Hemophilia Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Baxalta, Inc.

11.1.1 Baxalta, Inc. Company Detail

11.1.2 Baxalta, Inc. Business Overview

11.1.3 Baxalta, Inc. Acquired Hemophilia Treatment Introduction

11.1.4 Baxalta, Inc. Revenue in Acquired Hemophilia Treatment Business (2019-2024)

11.1.5 Baxalta, Inc. Recent Development

11.2 Baxter Healthcare Corporation

11.2.1 Baxter Healthcare Corporation Company Detail

11.2.2 Baxter Healthcare Corporation Business Overview

11.2.3 Baxter Healthcare Corporation Acquired Hemophilia Treatment Introduction

11.2.4 Baxter Healthcare Corporation Revenue in Acquired Hemophilia Treatment Business (2019-2024)

11.2.5 Baxter Healthcare Corporation Recent Development

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Detail

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Acquired Hemophilia Treatment Introduction

11.3.4 Bristol-Myers Squibb Revenue in Acquired Hemophilia Treatment Business (2019-2024)

11.3.5 Bristol-Myers Squibb Recent Development

11.4 Genentech, Inc.

11.4.1 Genentech, Inc. Company Detail

11.4.2 Genentech, Inc. Business Overview

11.4.3 Genentech, Inc. Acquired Hemophilia Treatment Introduction

11.4.4 Genentech, Inc. Revenue in Acquired Hemophilia Treatment Business (2019-2024)

11.4.5 Genentech, Inc. Recent Development

11.5 Novo Nordisk A/S

11.5.1 Novo Nordisk A/S Company Detail

11.5.2 Novo Nordisk A/S Business Overview

11.5.3 Novo Nordisk A/S Acquired Hemophilia Treatment Introduction

11.5.4 Novo Nordisk A/S Revenue in Acquired Hemophilia Treatment Business (2019-2024)

11.5.5 Novo Nordisk A/S Recent Development

11.6 Ferring B.V.

11.6.1 Ferring B.V. Company Detail

11.6.2 Ferring B.V. Business Overview

11.6.3 Ferring B.V. Acquired Hemophilia Treatment Introduction

11.6.4 Ferring B.V. Revenue in Acquired Hemophilia Treatment Business (2019-2024)

11.6.5 Ferring B.V. Recent Development

11.7 Sanofi SA

11.7.1 Sanofi SA Company Detail

11.7.2 Sanofi SA Business Overview

11.7.3 Sanofi SA Acquired Hemophilia Treatment Introduction

11.7.4 Sanofi SA Revenue in Acquired Hemophilia Treatment Business (2019-2024)

11.7.5 Sanofi SA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Baxalta

Baxter Healthcare Corporation

Bristol–Myers Squibb

Genentech Inc

Sanofi SA

List of Tables

Table 1. Global Acquired Hemophilia Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Traditional Therapy

Table 3. Key Players of Advanced Therapy

Table 4. Global Acquired Hemophilia Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Acquired Hemophilia Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Acquired Hemophilia Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Acquired Hemophilia Treatment Market Share by Region (2019-2024)

Table 8. Global Acquired Hemophilia Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Acquired Hemophilia Treatment Market Share by Region (2025-2030)

Table 10. Acquired Hemophilia Treatment Market Trends

Table 11. Acquired Hemophilia Treatment Market Drivers

Table 12. Acquired Hemophilia Treatment Market Challenges

Table 13. Acquired Hemophilia Treatment Market Restraints

Table 14. Global Acquired Hemophilia Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Acquired Hemophilia Treatment Market Share by Players (2019-2024)

Table 16. Global Top Acquired Hemophilia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired Hemophilia Treatment as of 2023)

Table 17. Ranking of Global Top Acquired Hemophilia Treatment Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Acquired Hemophilia Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Acquired Hemophilia Treatment Product Solution and Service

Table 21. Date of Enter into Acquired Hemophilia Treatment Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Acquired Hemophilia Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Acquired Hemophilia Treatment Revenue Market Share by Type (2019-2024)

Table 25. Global Acquired Hemophilia Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Acquired Hemophilia Treatment Revenue Market Share by Type (2025-2030)

Table 27. Global Acquired Hemophilia Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Acquired Hemophilia Treatment Revenue Market Share by Application (2019-2024)

Table 29. Global Acquired Hemophilia Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Acquired Hemophilia Treatment Revenue Market Share by Application (2025-2030)

Table 31. North America Acquired Hemophilia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Acquired Hemophilia Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Acquired Hemophilia Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Acquired Hemophilia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Acquired Hemophilia Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Acquired Hemophilia Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Acquired Hemophilia Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Acquired Hemophilia Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Acquired Hemophilia Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Acquired Hemophilia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Acquired Hemophilia Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Acquired Hemophilia Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Acquired Hemophilia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Acquired Hemophilia Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Acquired Hemophilia Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 46. Baxalta, Inc. Company Detail

Table 47. Baxalta, Inc. Business Overview

Table 48. Baxalta, Inc. Acquired Hemophilia Treatment Product

Table 49. Baxalta, Inc. Revenue in Acquired Hemophilia Treatment Business (2019-2024) & (US$ Million)

Table 50. Baxalta, Inc. Recent Development

Table 51. Baxter Healthcare Corporation Company Detail

Table 52. Baxter Healthcare Corporation Business Overview

Table 53. Baxter Healthcare Corporation Acquired Hemophilia Treatment Product

Table 54. Baxter Healthcare Corporation Revenue in Acquired Hemophilia Treatment Business (2019-2024) & (US$ Million)

Table 55. Baxter Healthcare Corporation Recent Development

Table 56. Bristol-Myers Squibb Company Detail

Table 57. Bristol-Myers Squibb Business Overview

Table 58. Bristol-Myers Squibb Acquired Hemophilia Treatment Product

Table 59. Bristol-Myers Squibb Revenue in Acquired Hemophilia Treatment Business (2019-2024) & (US$ Million)

Table 60. Bristol-Myers Squibb Recent Development

Table 61. Genentech, Inc. Company Detail

Table 62. Genentech, Inc. Business Overview

Table 63. Genentech, Inc. Acquired Hemophilia Treatment Product

Table 64. Genentech, Inc. Revenue in Acquired Hemophilia Treatment Business (2019-2024) & (US$ Million)

Table 65. Genentech, Inc. Recent Development

Table 66. Novo Nordisk A/S Company Detail

Table 67. Novo Nordisk A/S Business Overview

Table 68. Novo Nordisk A/S Acquired Hemophilia Treatment Product

Table 69. Novo Nordisk A/S Revenue in Acquired Hemophilia Treatment Business (2019-2024) & (US$ Million)

Table 70. Novo Nordisk A/S Recent Development

Table 71. Ferring B.V. Company Detail

Table 72. Ferring B.V. Business Overview

Table 73. Ferring B.V. Acquired Hemophilia Treatment Product

Table 74. Ferring B.V. Revenue in Acquired Hemophilia Treatment Business (2019-2024) & (US$ Million)

Table 75. Ferring B.V. Recent Development

Table 76. Sanofi SA Company Detail

Table 77. Sanofi SA Business Overview

Table 78. Sanofi SA Acquired Hemophilia Treatment Product

Table 79. Sanofi SA Revenue in Acquired Hemophilia Treatment Business (2019-2024) & (US$ Million)

Table 80. Sanofi SA Recent Development

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Acquired Hemophilia Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Acquired Hemophilia Treatment Market Share by Type: 2023 VS 2030

Figure 3. Traditional Therapy Features

Figure 4. Advanced Therapy Features

Figure 5. Global Acquired Hemophilia Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Acquired Hemophilia Treatment Market Share by Application: 2023 VS 2030

Figure 7. Hospitals Case Studies

Figure 8. Clinic Case Studies

Figure 9. Others Case Studies

Figure 10. Acquired Hemophilia Treatment Report Years Considered

Figure 11. Global Acquired Hemophilia Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Acquired Hemophilia Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Acquired Hemophilia Treatment Market Share by Region: 2023 VS 2030

Figure 14. Global Acquired Hemophilia Treatment Market Share by Players in 2023

Figure 15. Global Top Acquired Hemophilia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired Hemophilia Treatment as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Acquired Hemophilia Treatment Revenue in 2023

Figure 17. North America Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Acquired Hemophilia Treatment Market Share by Country (2019-2030)

Figure 19. United States Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Acquired Hemophilia Treatment Market Share by Country (2019-2030)

Figure 23. Germany Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Acquired Hemophilia Treatment Market Share by Region (2019-2030)

Figure 31. China Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Acquired Hemophilia Treatment Market Share by Country (2019-2030)

Figure 39. Mexico Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Acquired Hemophilia Treatment Market Share by Country (2019-2030)

Figure 43. Turkey Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Baxalta, Inc. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2019-2024)

Figure 46. Baxter Healthcare Corporation Revenue Growth Rate in Acquired Hemophilia Treatment Business (2019-2024)

Figure 47. Bristol-Myers Squibb Revenue Growth Rate in Acquired Hemophilia Treatment Business (2019-2024)

Figure 48. Genentech, Inc. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2019-2024)

Figure 49. Novo Nordisk A/S Revenue Growth Rate in Acquired Hemophilia Treatment Business (2019-2024)

Figure 50. Ferring B.V. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2019-2024)

Figure 51. Sanofi SA Revenue Growth Rate in Acquired Hemophilia Treatment Business (2019-2024)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions